Hidaka H - Search Results

1

Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model.

Inoue Y, Toga K, Sudo T, Tachibana K, Tochizawa S, Kimura Y, Yoshida Y, Hidaka H. Inoue Y, et al. Among authors: hidaka h. Br J Pharmacol. 2000 May;130(2):231-41. doi: 10.1038/sj.bjp.0703287. Br J Pharmacol. 2000. PMID: 10807659 Free PMC article.

2

Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.

Sudo T, Tachibana K, Toga K, Tochizawa S, Inoue Y, Kimura Y, Hidaka H. Sudo T, et al. Among authors: hidaka h. Biochem Pharmacol. 2000 Feb 15;59(4):347-56. doi: 10.1016/s0006-2952(99)00346-9. Biochem Pharmacol. 2000. PMID: 10644042

3

2(1H)-quinolinone derivatives as novel anti-arteriostenotic agents showing anti-thrombotic and anti-hyperplastic activities.

Koga Y, Kihara Y, Okada M, Inoue Y, Tochizawa S, Toga K, Tachibana K, Kimura Y, Nishi T, Hidaka H. Koga Y, et al. Among authors: hidaka h. Bioorg Med Chem Lett. 1998 Jun 16;8(12):1471-6. doi: 10.1016/s0960-894x(98)00246-7. Bioorg Med Chem Lett. 1998. PMID: 9873372

4

Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells.

Tani T, Sakurai K, Kimura Y, Ishikawa T, Hidaka H. Tani T, et al. Among authors: hidaka h. Adv Second Messenger Phosphoprotein Res. 1992;25:215-27. Adv Second Messenger Phosphoprotein Res. 1992. PMID: 1372812 No abstract available.

5

Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor Sepharose chromatography.

Umekawa H, Tanaka T, Kimura Y, Hidaka H. Umekawa H, et al. Among authors: hidaka h. Biochem Pharmacol. 1984 Nov 1;33(21):3339-44. doi: 10.1016/0006-2952(84)90103-5. Biochem Pharmacol. 1984. PMID: 6093810

6

Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.

Hidaka H, Hayashi H, Kohri H, Kimura Y, Hosokawa T, Igawa T, Saitoh Y. Hidaka H, et al. J Pharmacol Exp Ther. 1979 Oct;211(1):26-30. J Pharmacol Exp Ther. 1979. PMID: 226672 No abstract available.

7

[Annexin family].

Hidaka H, Sudo T. Hidaka H, et al. Tanpakushitsu Kakusan Koso. 1998 Sep;43(12 Suppl):1652-8. Tanpakushitsu Kakusan Koso. 1998. PMID: 9788165 Review. Japanese. No abstract available.

8

Regulation of calcyclin (S100A6) binding by alternative splicing in the N-terminal regulatory domain of annexin XI isoforms.

Sudo T, Hidaka H. Sudo T, et al. Among authors: hidaka h. J Biol Chem. 1998 Mar 13;273(11):6351-7. doi: 10.1074/jbc.273.11.6351. J Biol Chem. 1998. PMID: 9497364 Free article.

9

Characterization of the calcyclin (S100A6) binding site of annexin XI-A by site-directed mutagenesis.

Sudo T, Hidaka H. Sudo T, et al. Among authors: hidaka h. FEBS Lett. 1999 Feb 5;444(1):11-4. doi: 10.1016/s0014-5793(99)00014-9. FEBS Lett. 1999. PMID: 10037139 Free article.

10

Isoform-specific intracellular vesicle formation by recombinant annexin XI-A in Sf9 cells.

Sudo T, Mamiya N, Goto M, Watanabe Y, Hidaka H. Sudo T, et al. Among authors: hidaka h. Biochem Biophys Res Commun. 1996 Jun 25;223(3):706-11. doi: 10.1006/bbrc.1996.0967. Biochem Biophys Res Commun. 1996. PMID: 8687461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,151 results

Search Page

Filters